Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer

Saved in:
Bibliographic Details
Published in:Cancer Management and Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552787360481280
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Management and Research
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61114
institution FRELIP
journal_source_facet Cancer Management and Research
last_indexed 2026-06-20T21:26:07.255Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
title_alt Eficacia clínica y análisis de seguridad de inhibidores de CDK4/6 combinados con ET en pacientes con cáncer de mama avanzado HR+HER2−
Efficacité clinique et analyse de sécurité des inhibiteurs de CDK4/6 combinés à l'ET chez les patientes atteintes d'un cancer du sein avancé RH+HER2−
Eficácia clínica e análise de segurança de inibidores de CDK4/6 combinados com ET em pacientes com câncer de mama avançado HR+HER2−
title_auth Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
title_es_txt Eficacia clínica y análisis de seguridad de inhibidores de CDK4/6 combinados con ET en pacientes con cáncer de mama avanzado HR+HER2−
title_fr_txt Efficacité clinique et analyse de sécurité des inhibiteurs de CDK4/6 combinés à l'ET chez les patientes atteintes d'un cancer du sein avancé RH+HER2−
title_full Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
title_fullStr Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
title_full_unstemmed Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
title_pt_txt Eficácia clínica e análise de segurança de inibidores de CDK4/6 combinados com ET em pacientes com câncer de mama avançado HR+HER2−
title_short Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
title_sort clinical efficacy and security analysis of cdk4/6 inhibitors combined with et in patients with hr+her2− advanced breast cancer
topic Oncology
General
Oncology
url https://www.dovepress.com/clinical-efficacy-and-security-analysis-of-cdk46-inhibitors-combined-w-peer-reviewed-fulltext-article-CMAR